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The pathogenesis of Graves-Basedow's disease is similar to that of Hashimoto’s disease (chronic autoimmune 
thyroiditis) and it is assumed that these two forms are the opposite poles of the same autoimmune disease. The 
name of the first disease derives from the surnames of two scientists who described it in the literature: Robert 
James Graves (1835) and Karl Adolf von Basedow (1840). The first description of the second disease was 
presented in 1912 by Hakaru Hashimoto. Genetic, environmental and endogenic factors are involved in the 
pathogenesis of autoimmune diseases. Genetic predisposition to an autoimmune disease depends on many genetic 
loci, of which three seem to be most important: alleles of the major histocompatibility system genes (human 
leukocyte antigen – HLA), mainly of class II HLA-DR3 and DR5; alleles of the gene encoding antigen-4 
associated with the cytotoxic T lymphocyte (cytotoxic T lymphocyte associated antigen-4 – CTLA-4) and alleles 
of the gene encoding the lymphocytic tyrosine phosphatase (Protein Tyrosine Phosphatase Non Receptor – Type 
22 - PTPN22). Epidemiological studies also confirm that genetic factors are responsible for autoimmune thyroid 
diseases with a high prevalence in patients’ relatives, especially among monozygotic twins. The environmental 
factors responsible for the presence of thyroid autoantigens on thyrocyte surface include viral infection, extreme 
stress, an excessive iodine content in diet, the action of some drugs (interferon α, amiodarone) and a huge number 
of chemical compounds in polluted surroundings. The most important endogenic factors include female sex and the 
phenomenon of foetal microchimerism in pregnant women. An organ-specific suppressor T lymphocyte defect 
develops in genetically predisposed people, which leads to an excessive stimulation of the T-helper lymphocytes. 
As a consequence, B lymphocytes experience excessive stimulation with subsequent production of plasma cells, 
which are responsible for the disproportionate production of antibodies against thyroid antigens – mainly the TSH 
receptor, thyroglobulin and thyroid peroxidase. In Graves-Basedow's disease, TSH receptor is the main autoantigen 
against which the antithyroid antibodies are directed. High titres of ATG and anti-TPO may suggest the 
coexistence of Hashimoto’s disease. In 80% cases of Graves-Basedow's disease, TSHR antibodies are stimulatory 
(thyroid stimulating immunoglobulins – TSI). In some cases, antibodies that inhibit thyrotropin binding to thyroid 
cells are produced (thyrotropin binding inhibiting immunoglobulins – TBII), which may lead to the development of 
hypothyroidism. 
In Hashimoto’s disease, cytotoxic lymphocytes, able to destroy thyroid follicular cells, receive considerable 
stimulation. Apart from cytotoxic lymphocytes, macrophages and the phenomenon of programmed cell death 
(apoptosis) also take part in the process of thyrocyte destruction. Clinical diagnosis of Graves-Basedow's disease is 
based on the detection of evenly enlarged thyroid gland with tactile fremitus and/or audible vascular murmur and 
the occurrence of the typical ophthalmic changes. Some patients also suffer from pretibial myxoedema and thyroid 
acropathy. Ultrasonography is a very useful imaging tool in the diagnosis of Graves-Basedow's disease – the 
thyroid gland is usually enlarged and has a homogenous, hypoechoic structure. Scintigraphy is not obligatory in 
each case of Graves-Basedow's disease, but it is very helpful in patients with the features of nodular structure and 
in the form without the goitre in which diagnostic difficulties occur. In the classical form of Hashimoto’s disease, a 
painless goitre of intensified cohesion presents with a butterfly-like shape because of the palpable pyramidal lobe. 
Patients complain of pressure and feeling of obstruction within the neck, and can report swallowing disorders and 
hoarseness. Chronic autoimmune thyroiditis can also occur in the atrophic, focal and juvenile form. Additionally, 
there are two variants of Hashimoto’s disease: postpartum thyroiditis and silent, painless thyroiditis. High anti-TPO 
antibody concentrations confirm the diagnosis of Hashimoto’s disease or any of its variants. The absence of 
antibodies in serum does not exclude lymphocytic thyroiditis as they are provided by intrathyroid lymphocyte 
infiltrations. Some authors attribute a special diagnostic significance to fine-needle aspiration biopsy in 
seronegative forms. Ultrasound thyroid examination is helpful in establishing correct diagnosis. Heterogeneous and 
distinctly hypoechoic structures of the thyroid gland are typical sonographic manifestations. 
